CompoAtlas

Féminin Sacré - Pleine Lune

Food supplement declared in France, declaration No 2023-8-329

Féminin Sacré - Pleine Lune (Ælixir Ælchimique) is a food supplement declared in France. Status: withdrawal from the market announced for 30 November 2028. Main ingredients: Alchemilla vulgaris 335 mg per day, Achillea millefolium 206 mg per day, Vitex agnus-castus 129 mg per day, Rubus idaeus 60 mg per day, miel. 1 rule of use applies to its ingredients (limits and warnings).

Brand
Ælixir Ælchimique
Food business operator placing the product on the market
VITURET Florent
Status
Withdrawal from the market announced for 30 November 2028
Form
Dropper
Daily dose
90 gouttes soit 834mg d'extrait
Directions for use
30 gouttes diluées dans un verre d'eau, 3 fois par jour pendant 3 semaines.
Intended populations
Women
Not recommended (according to the manufacturer)
Breastfeeding women, History of breast cancer, Children (under 12), Young children (aged 1 to 3), Pregnant women, Taking anticoagulants, Taking antidepressants, Taking blood pressure medication, Taking medication, Taking thyroid medication, Children (under 6), Children (under 10)
Objectives stated by the manufacturer (these are not authorised claims)
Menstrual cycles, Mood

Declaration 272222, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Alchemilla vulgaris L.Parties aériennesAlcoolature335 mg
Achillea millefolium L.Sommités fleuriesAlcoolature206 mg
Vitex agnus-castus L.FruitAlcoolature129 mg
Rubus idaeus L.Jeune pousseAutre macérât60 mg

Other active ingredients

NamePer day
mielnot declared
Eau de mernot declared

Other ingredients

Eau osmosée dynamisée, Alcool

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Ce produit additionne les contre-indications de chacune des plantes qui le compose, il est donc contre-indiqué à la femme enceinte, allaitante, à l'enfant de moins de 12 ans, en cas d'antécédant de cancer du sein, à l'Homme et à toutes personnes sous traitement médicamenteux ou en cours de fécondation In-Vitro. Détail :L'Alchémille est contre-indiqué à la femme enceinte, allaitante et à l'enfant de moins de 12 ans (alcool) ;L'Achillée Millefeuille nécessite une surveillance médicale en cas de traitement anti-coagulant ;Le Gattilier est en plus contre-indiqué à l'Homme, aux personnes sous fécondations in-vitro et en cas de traitements médicamenteux par mesure de précaution.Le Framboisier n'ajoute pas de contre-indications supplémentaires.

Regulatory points

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Vitex agnus-castus L.
    Read the warning, when it applies and the studies cited

    CHASTE TREE - VITEX AGNUS-CASTUS

    Route of administration: Oral (WHO 2009; Bradley 2006; Mills and Bone 2000)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking hormone-containing medications such as progesterone preparations, oral contraceptives or hormone replacement therapy (Brinker 2010; WHO 2009; Bradley 2006).

    Sources cited by Health Canada (4)
    • Bradley PR, editor. 2006. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (GB): British Herbal Medicine Association.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • WHO 2009: World Health Organization. WHO Monographs on Selected Medicinal Plants, Volume 4. Geneva (CH): World Health Organization.
    • OMS 2009: Organisation mondiale de la santé. WHO Monographs on Selected Medicinal Plants, Volume 4. Genève (CH): Organisation mondiale de la santé.

    Contraindications

    Do not use if you are pregnant, breastfeeding or attempting to conceive unless you have consulted with a health care practitioner/health care provider/health care professional/doctor/physician (EMA 2018; Najib et al. 2022; Brinker 2010; WHO 2009; Dugoua et al. 2008; ESCOP 2003; Blumenthal 2000; Mills and Bone 2000).

    Sources cited by Health Canada (9)
    • Blumenthal M, Goldberg A, Brinkmann J, editors. 2000. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Dugoua JJ, Seely D, Pern D, Koren G, Mills E. Safety and efficacy of chastetree (Vitex Agnus-Castus) during pregnancy and lactation. Can J. Clin Pharmacol 2008;15(1);e74-e79.
    • EMA 2018. European Medicines Agency. European Union herbal monograph on Vitex agnus-castus L., fructus. London (GB): EMA Committee on Herbal Medicinal Products (HMPC); 27 March 2018. [Accessed 2024 February 29] Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-vitex-agnus-castus-l-fructus-revision-1_en.pdf
    • ESCOP 2003: European Scientific Cooperative on Phytotherapy Scientific Committee. ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy in collaboration with Thieme.
    • Mills S, Bone K. 2000. Principles and Practice of Phytotherapy. Toronto (ON): Churchill Livingstone.
    • Najib FS, Poordast T, Mahmudi MS, Shiravani Z, Namazi N, Omrani GR. Does Vitex Agnus-Castus L. Have Deleterious Effect on Fertility and Pregnancy Outcome? An Experimental Study on Rats for Prediction of Its Safety. J. Pharmacopuncture 2022;25(2):106-113. PubMed
    • WHO 2009: World Health Organization. WHO Monographs on Selected Medicinal Plants, Volume 4. Geneva (CH): World Health Organization.
    • OMS 2009: Organisation mondiale de la santé. WHO Monographs on Selected Medicinal Plants, Volume 4. Genève (CH): Organisation mondiale de la santé.

    Health Canada monograph dated 28 March 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : Ælixir Ælchimique

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Féminin Sacré - Pleine Lune (Ælixir Ælchimique): composition and regulation”, https://compoatlas.com/en/supplements/products/272222-feminin-sacre-pleine-lune, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line